Mieloma Después de la Recaída: Lo Que la Nueva Investigación Significa para los Pacientes
https://vimeo.com/1160265495 La Dra. Krina K. Patel del Centro de Cáncer MD Anderson de la Universidad de Texas analiza datos alentadores del ensayo clínico MAJESTIC-3, que estudió una combinación de dos…
Myeloma After Relapse: What New Research Means for Patients
Dr. Krina K. Patel of The University of MD Anderson Cancer Center discusses encouraging new data from the MAJESTIC-3 clinical trial, which studied a combination of two immunotherapies for people…
ELEVATE | From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients
https://vimeo.com/1159341084 What if myeloma returns after CAR T-cell therapy? Dr. Doris Hansen reviews additional options for patients, including repeat CAR-T treatments, bispecific and trispecific immunotherapies, and other emerging drugs in…
How AI Is Shaping the Future of CAR T and Myeloma Care
https://vimeo.com/1158519733 Exploring the intersection of artificial intelligence and next-generation cancer therapies, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of The…
Staying [ACT]IVATED Ahead of Relapse: Improving CAR T Durability in Myeloma
https://vimeo.com/1158519769 In a forward-looking discussion on the future of CAR T-cell therapy, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of…
Getting to CAR T: How Patients Can Overcome Access Barriers
https://vimeo.com/1158519876 Exploring the real-world barriers that can delay access to CAR T-cell therapy, Lisa Hatfield, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center…
Coordinating Care After CAR T: Staying Safe and Connected
https://vimeo.com/1158519831 Lisa Hatfield, PEN’s Myeloma Empowerment Lead, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center about best practices for coordinating care after CAR…
Bridging Therapy & Lymphodepletion: What to Expect on the CAR T Timeline
https://vimeo.com/1158519915 Lisa Hatfield, PEN’s Empowerment Lead who is living with multiple myeloma, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center about key treatment…
Staying [ACT]IVATED: When to Ask About CAR T in Your Myeloma Journey
https://vimeo.com/1158519999 Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center discusses when and how patients with multiple myeloma should start conversations about CAR T-cell therapy. She…
ELEVATE | From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients Resource Guide
Download Resource Guide Download Resource Guide See More from ELEVATE CAR T-Cell Therapy
What Are Myeloma Treatment Options After CAR T-Cell Therapy?
https://vimeo.com/1147680083 What if myeloma returns after CAR T-cell therapy? Dr. Doris Hansen reviews additional options for patients, including repeat CAR-T treatments, bispecific and trispecific immunotherapies, and other emerging drugs in…
Understanding and Managing CAR T-Cell Therapy Side Effects | What You Should Know
https://vimeo.com/1147680103 Dr. Doris Hansen from Moffit Cancer Center shares an overview of the common side effects of CAR T-cell therapy, such as cytokine release syndrome (CRS), low blood counts, and…